Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Lennox–Gastaut syndrome (LGS) is a severe epileptic and developmental encephalopathy that is associated with a high rate of morbidity and mortality. It is characterized by multiple seizure types, abnormal electroencephalographic features, and intellectual disability. Although intellectual disability and associated behavioral problems are characteristic of LGS, they are not necessarily present at its outset and are therefore not part of its diagnostic criteria. LGS is typically treated with a variety of pharmacological and non-pharmacological therapies, often in combination. Management and treatment decisions can be challenging, due to the multiple seizure types and comorbidities associated with the condition. A panel of five epileptologists met to discuss consensus recommendations for LGS management, based on the latest available evidence from literature review and clinical experience. Treatment algorithms were formulated. Current evidence favors the continued use of sodium valproate (VPA) as the first-line treatment for patients with newly diagnosed de novo LGS. If VPA is ineffective alone, evidence supports lamotrigine, or subsequently rufinamide, as adjunctive therapy. If seizure control remains inadequate, the choice of next adjunctive antiepileptic drug (AED) should be discussed with the patient/parent/caregiver/clinical team, as current evidence is limited. Non-pharmacological therapies, including resective surgery, the ketogenic diet, vagus nerve stimulation, and callosotomy, should be considered for use alongside AED therapy from the outset of treatment. For patients with LGS that has evolved from another type of epilepsy who are already being treated with an AED other than VPA, VPA therapy should be considered if not trialed previously. Thereafter, the approach for a de novo patient should be followed. Where possible, no more than two AEDs should be used concomitantly. Patients with established LGS should undergo review by a neurologist specialized in epilepsy on at least an annual basis, including a thorough reassessment of their diagnosis and treatment plan. Clinicians should always be vigilant to the possibility of treatable etiologies and alert to the possibility that a patient’s diagnosis may change, since the seizure types and electroencephalographic features that characterize LGS evolve over time. In all LGS patients, To date, available treatments are unlikely to lead to seizure remission in the majority of patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial
Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., Whitney, A., & Cross, J. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70092-9 · Cited by 1,224 · cited 1×
“The most common AEs were constipation, vomiting, hunger, and lack of energy (67).”
BackgroundSelf-citationCannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00379-8 · Cited by 900
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745 · cited 1×
“In addition, prolonged use of steroids is associated with serious AEs, including growth suppression, hyperlipidemia, and osteoporosis (66).”
BackgroundThe longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 580
Vagus-nerve stimulation for the treatment of epilepsy
Ben-Menachem, E. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00220-x · Cited by 560
Antiepileptic Drugs as a Cause of Worsening Seizures
Perucca, E., Gram, L., Avanzini, G., & Dulac, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01268.x · Cited by 543 · cited 1×
“, cognitive impairment, depression), and the choice of AED treatment must therefore take this possibility into consideration; for example, benzodiazepines used to treat sleep disorders may precipitate tonic seizures in LGS (106).”
BackgroundDrug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015) · Epilepsia · doi:10.1111/epi.13060 · Cited by 496 · cited 1×
“Some of these side effects may be attributable to comedication; cannabidiol is a potent inhibitor of enzymes in the cytochrome P450 pathway, and a definitive interaction has been reported with at least CLB (62).”
BackgroundArzimanoglou, A., French, J., Blume, W. T., Cross, J. H., Ernst, J.-P., Feucht, M., Genton, P., Guerrini, R., Kluger, G., Pellock, J. M., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70292-8 · Cited by 491 · cited 10×
“It is important to consider that a patient’s QoL may be impaired more by the side effects of treatment than by the seizures themselves (4) and clinicians should always be vigilant for adverse drug effects.”
BackgroundInfluentialSelf-citationPatry, G. (1971) · Archives of Neurology · doi:10.1001/archneur.1971.00480330070006 · Cited by 489 · cited 1×
“The syndrome of Epileptic Encephalopathy with Continuous Spike Wave of Slow Sleep may also manifest with drop attacks as a predominant seizure manifestation, with evidence of neurodevelopmental regression at presentation, but on evaluation although bursts of SSW are seen with atonic absence seizures when awake, prolon…”
BackgroundMorris, G. L., Gloss, D., Buchhalter, J., Mack, K. J., Nickels, K., & Harden, C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a393d1 · Cited by 450
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439 · cited 3×
“Collaboration between the EuroEPINOMICS and Epi4K/ EPGP consortia allowed the analysis of exome-sequencing data from a cohort of 356 trios with LGS or infantile spasms, and found a total of 429 de novo mutations (17).”
BackgroundInfluentialSelf-citationGASTAUT, H., ROGER, J., SOULAYROL, R., TASSINARI, C. A., RÉGIS, H., DRAVET, C., BERNARD, R., PINSARD, N., & SAINT‐JEAN, M. (1966) · Epilepsia · doi:10.1111/j.1528-1167.1966.tb06263.x · Cited by 431 · cited 4×
“Although intellectual disability and associated behavioral problems were originally described in all patients by Lennox and Gastaut (1), they are not necessarily present at its outset and, consequently, their presence or absence are not included in the diagnostic criteria.”
BackgroundInfluentialEfficacy of Felbamate in Childhood Epileptic Encephalopathy (Lennox-Gastaut Syndrome)
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280105 · Cited by 407
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G., & the Topiramate YL Study Group (1999) · Neurology · doi:10.1212/wnl.52.9.1882 · Cited by 380 · cited 1×
“TPM was shown to be effective in the treatment of LGS in a Phase III placebo-controlled RCT conducted in 98 patients with LGS (43) (Table 2).”
MethodLamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Motte, J., Trevathan, E., Arvidsson, J. F. V., Barrera, M. N., Mullens, E. L., & Manasco, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372504 · Cited by 359
Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome
Glauser, T., Kluger, G., Sachdeo, R., Krauss, G., Perdomo, C., & Arroyo, S. (2008) · Neurology · doi:10.1212/01.wnl.0000303813.95800.0d · Cited by 356 · cited 1×
“RUF’s effectiveness in LGS was demonstrated in a Phase III placebo-controlled RCT conducted in 138 patients with LGS (42) (Table 2).”
BackgroundSuccessful surgery for epilepsy due to early brain lesions despite generalized EEG findings
Wyllie, E., Lachhwani, D. K., Gupta, A., Chirla, A., Cosmo, G., Worley, S., Kotagal, P., Ruggieri, P., & Bingaman, W. E. (2007) · Neurology · doi:10.1212/01.wnl.0000266386.55715.3f · Cited by 329 · cited 1×
“Successful surgical outcomes have been reported in patients with a congenital brain abnormality that was predominantly focal on MRI, despite most of the epileptiform discharges being generalized (74).”
BackgroundTreatment of pediatric epilepsy: European expert opinion, 2007
Wheless, J. W., Clarke, D. F., Arzimanoglou, A., & Carpenter, D. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0144 · Cited by 295
Self-citationOrosz, I., McCormick, D., Zamponi, N., Varadkar, S., Feucht, M., Parain, D., Griens, R., Vallée, L., Boon, P., Rittey, C., et al. (2014) · Epilepsia · doi:10.1111/epi.12762 · Cited by 269 · cited 1×
“A pan-European, retrospective, multicenter study investigated the effectiveness of VNS in 347 children with drug-resistant epilepsy over a follow-up period of up to 24 months (81).”
BackgroundSelf-citationValproate in the treatment of epilepsy in girls and women of childbearing potential
Tomson, T., Marson, A., Boon, P., Canevini, M. P., Covanis, A., Gaily, E., Kälviäinen, R., & Trinka, E. (2015) · Epilepsia · doi:10.1111/epi.13021 · Cited by 267 · cited 1×
“International League Against Epilepsy guidelines recommend that VPA should be avoided where possible in women of childbearing potential, but recognize that, for seizure (or epilepsy) types where VPA is the most effective treatment, the risks and benefits of VPA and other treatment alternatives should be discussed, and…”
BackgroundSodium valproate acutely inhibits lamotrigine metabolism.
Yuen, A., Land, G., Weatherley, B., & Peck, A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04079.x · Cited by 252 · cited 19×
“The conclusion was that no one drug appears highly effective in LGS over and above another: lamotrigine (LTG), rufinamide (RUF), topiramate (TPM), and felbamate (FLB) may all be useful as adjunctive therapy and clobazam (CLB) may be useful for drop attacks.”
InfluentialAtypical Benign Partial Epilepsy of Childhood
Aicardi, J., & Chevrie, J. J. (1982) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1982.tb13620.x · Cited by 250 · cited 1×
“Five years after LGS onset, 75–95% of patients have cognitive impairment (101, 102), and behavioral problems, such as hyperactivity, aggressiveness, and autistic traits, develop in approximately 50% (10).”
BackgroundVagus Nerve Stimulation in Children with Refractory Seizures Associated with Lennox–Gastaut Syndrome
Frost, M., Gates, J., Helmers, S. L., Wheless, J. W., Levisohn, P., Tardo, C., & Conry, J. A. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.23900.x · Cited by 240
Hussain, S. A., Zhou, R., Jacobson, C., Weng, J., Cheng, E., Lay, J., Hung, P., Lerner, J. T., & Sankar, R. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.009 · Cited by 220 · cited 1×
“in the Treatment of LGS Cannabidiol has some evidence of efficacy and an adequate safety profile when used as adjunctive therapy in children and young adults with treatment-resistant epilepsies, including LGS and Dravet syndrome (60, 61).”
BackgroundKivity, S., Lerman, P., Ariel, R., Danziger, Y., Mimouni, M., & Shinnar, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.30503.x · Cited by 210
Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood
Oguni, H., Tanaka, T., Hayashi, K., Funatsuka, M., Sakauchi, M., Shirakawa, S., & Osawa, M. (2002) · Neuropediatrics · doi:10.1055/s-2002-33675 · Cited by 200 · cited 1×
“This particular example illustrates where delineating a correct syndrome diagnosis is of considerable prognostic importance; approximately two-thirds of patients with MAE have a favorable prognosis (25), whereas in LGS this is lacking.”
BackgroundAdvances in epileptology : XIIIth Epilepsy International Symposium
Akimoto, H. (1982) · Raven Press eBooks · Cited by 194
The early-infantile epileptic encephalopathy with suppression-burst: Developmental aspects
Ohtahara, S., Ohtsuka, Y., Yamatogi, Y., & Oka, E. (1987) · Brain and Development · doi:10.1016/s0387-7604(87)80110-9 · Cited by 193
Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome
Ng, Y. T., Conry, J. A., Drummond, R., Stolle, J., & Weinberg, M. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318232de76 · Cited by 191 · cited 1×
“The effectiveness of CLB in the treatment of LGS was demonstrated in a placebo-controlled Phase III RCT conducted in 238 patients with LGS (44) (Table 2).”
BackgroundTreatment of Lennox-Gastaut syndrome
Hancock, E. C., & Cross, J. H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003277.pub3 · Cited by 187
Self-citationNonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports
Walker, M., Cross, H., Smith, S., Young, C., Aicardi, J., Appleton, R., Aylett, S., Besag, F., Cock, H., DeLorenzo, R., et al. (2005) · Epileptic Disorders · doi:10.1684/j.1950-6945.2005.tb00130.x · Cited by 181 · cited 2×
“A high index of suspicion is therefore required on the part of the physician, particularly if a previous baseline EEG is not available for comparison (94).”
BackgroundThe Neurocognitive Effects of Sleep Disruption in Children and Adolescents
O'Brien, L. M. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.04.008 · Cited by 180 · cited 1×
“Sleep deprivation and/or disruption affect the neurophysiological and neurochemical mechanisms important for the memory-learning process (104), and may also result in a wide range of behavioral, cognitive, and mood impairments, including hyperactivity, reduced school grades, and depression (105).”
BackgroundChildhood Epileptic Encephalopathy with Slow Spike‐Wave A Statistical Study of 80 Cases
CHEVRIE, J. J., & AICARDI, J. (1972) · Epilepsia · doi:10.1111/j.1528-1157.1972.tb05260.x · Cited by 179 · cited 3×
“Neuropsychiatr Dis Treat (2008) 4(6):1001–19.”
BackgroundInfluentialShahwan, A., Bailey, C., Maxiner, W., & Harvey, A. S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01940.x · Cited by 173 · cited 1×
“Patients treated with VNS appear to show continuing improvement over time and some demonstrate improvement in alertness (83).”
BackgroundThe Neurocognitive Effects of Sleep Disruption in Children and Adolescents
O'Brien, L. M. (2011) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.12.007 · Cited by 170
Lancman, G., Virk, M., Shao, H., Mazumdar, M., Greenfield, J. P., Weinstein, S., & Schwartz, T. H. (2013) · Seizure · doi:10.1016/j.seizure.2012.09.014 · Cited by 163
A blinded, crossover study of the efficacy of the ketogenic diet
Freeman, J. M., Vining, E. P. G., Kossoff, E. H., Pyzik, P. L., Ye, X., & Goodman, S. N. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01740.x · Cited by 150 · cited 2×
“There were, however, methodological flaws to the study; the glucose group never lost their ketosis, and seizure counts were initiated after fasting (68).”
BackgroundClobazam in the treatment of Lennox‐Gastaut syndrome
Conry, J. A., Ng, Y., Paolicchi, J., Kernitsky, L., Mitchell, W. G., Ritter, F. J., Collins, S. D., Tracy, K. A., Kormany, W. N., Abdulnabi, R., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01935.x · Cited by 136 · cited 1×
“Patients completing this RCT and a previous Phase II study (54) were eligible to enter a long-term, open-label extension study (n = 267) (55).”
Aicardi's Epilepsy in Children
Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00881.x · Cited by 136
Doose, H. (1992) · PubMed · Cited by 126
Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study
Kluger, G. J., Glauser, T. A., Krauss, G. L., Seeruthun, R., Perdomo, C. A., & Arroyo, S. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01334.x · Cited by 126 · cited 2×
“Reductions in seizure frequency were maintained throughout the study and tolerability observed in the initial trial was also maintained with long-term treatment (50).”
BackgroundMethodSleep and epilepsy in children and adolescents
Kothare, S. V., & Kaleyias, J. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.01.012 · Cited by 125 · cited 11×
“LGS also has a major impact on the QoL of parents/carers and families due to restriction of social life and relationship problems between partners and other family members; feelings of isolation, which can lead to depression; problems with childcare, which can further restrict social participation and opportunities fo…”
BackgroundInfluentialLong‐term Prognosis for Symptomatic (Secondarily) Generalized Epilepsies: A Population‐based Study
Camfield, P., & Camfield, C. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01072.x · Cited by 125 · cited 2×
“Even with current and new pharmacological agents, seizure freedom is highly unlikely to be achieved (34).”
BackgroundWhen do seizures usually improve with the ketogenic diet?
Kossoff, E. H., Laux, L. C., Blackford, R., Morrison, P. F., Pyzik, P. L., Hamdy, R. M., Turner, Z., & Nordli, D. R. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01417.x · Cited by 122 · cited 1×
“Since a response to the KD is usually observed within 3 months (90), this therapeutic option can be explored relatively quickly.”
BackgroundEriksson, A., Nergårdh, A., & Hoppu, K. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01411.x · Cited by 121 · cited 1×
“In addition, in a double-blind, placebo-controlled, crossover study conducted in 30 pediatric and adolescent patients with refractory generalized epilepsy, 20 of whom had LGS, LTG was well tolerated and a statistically significant reduction in seizure frequency was observed with LTG, compared with placebo (47).”
BackgroundOccurrence, Outcome, and Prognostic Factors of Infantile Spasms and Lennox‐Gastaut Syndrome
Rantala, H., & Putkonen, T. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00705.x · Cited by 118 · cited 2×
“• Epileptic spasms: LGS develops from West syndrome in approximately 30% of pediatric cases (9, 10) and such patients may continue to have epileptic spasms during evolution to LGS (11).”
BackgroundThe relationship between sleep and epilepsy: the effect on cognitive functioning in children
Parisi, P., Bruni, O., Villa, M. P., Verrotti, A., Miano, S., Luchetti, A., & Curatolo, P. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03662.x · Cited by 117 · cited 1×
“Sleep deprivation and/or disruption affect the neurophysiological and neurochemical mechanisms important for the memory-learning process (104), and may also result in a wide range of behavioral, cognitive, and mood impairments, including hyperactivity, reduced school grades, and depression (105).”
BackgroundGoldsmith, I. L., Zupanc, M. L., & Buchhalter, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00179.x · Cited by 112 · cited 4×
“Many cases occur as a result of a brain abnormality caused by, for example, a brain insult, developmental malformation, infection, or tumor (5), or a genetic mutation.”
BackgroundInfluentialCAMFIELD, P. R., Camfield, C., & Pohlmann‐Eden, B. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.4s.13 · Cited by 110 · cited 1×
“Specialist “transition clinics” or “teenager clinics” can help ease the transitional process (98, 99), and, for adolescent patients being treated with KD therapy, attendance at an adult epilepsy diet center can help ensure that an effective transition plan is in place (100).”
BackgroundTreatment of Lennox-Gastaut syndrome: overview and recent findings
van Rijckevorsel, K. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1668 · Cited by 108 · cited 3×
“Five years after LGS onset, 75–95% of patients have cognitive impairment (101, 102), and behavioral problems, such as hyperactivity, aggressiveness, and autistic traits, develop in approximately 50% (10).”
BackgroundLemmon, M. E., TERAO, N. N., Ng, Y., REISIG, W., Rubenstein, J. E., & Kossoff, E. H. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2012.04233.x · Cited by 107 · cited 3×
“Similar results were observed after 12 months (69).”
BackgroundResultInfluentialStephani, U., Tarallo, T., Bast, T., Schlachter, K., Fleger, M., Kurlemann, G., Fiedler, B. J., Leiz, S., Nikanorova, M., Wolff, M., et al. (2015) · Neuropediatrics · doi:10.1055/s-0035-1546276 · Cited by 107 · cited 6×
“Ethosuximide can be useful for the treatment of absence seizures, but should always be combined with an AED that is effective in treating generalized tonic–clonic seizures and tonic/atonic seizures, since it is not effective for these seizure FiGURe 1 | Treatment algorithm for a newly diagnosed patient with LGS. aNot…”
BackgroundInfluentialDodson, W. E. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb04590.x · Cited by 106 · cited 1×
“Patients completing this trial could continue into a 12-month, open-label extension study, during which improvement in seizure control observed in the initial trial was sustained: at Month 12, responder rates (response defined as >50% reduction from RCT baseline) were approximately 50% for total seizures and approxima…”
BackgroundLarsen, J., Johannesen, K. M., Ek, J., Tang, S., Marini, C., Blichfeldt, S., Kibæk, M., von Spiczak, S., Weckhuysen, S., Frangu, M., et al. (2015) · Epilepsia · doi:10.1111/epi.13222 · Cited by 101
Self-citationLennox–Gastaut syndrome in adulthood: Clinical and EEG features
Ferlazzo, E., Nikaronova, M., Italiano, D., Bureau, M., Dravet, C., Calarese, T., Viallat, D., Kölmel, M. S., Bramanti, P., Santi, L. D., et al. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.01.012 · Cited by 90 · cited 3×
“Epidemiological follow-up data and review of adults with LGS suggest that, with standard treatments, there is a very low likelihood of remission in the long term, confirming the ongoing challenges faced in seizure management (16, 34).”
BackgroundDevelopment and Implementation of an Adolescent Epilepsy Transition Clinic
Jurasek, L., Ray, L. D., & Quigley, D. (2010) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3181e26be6 · Cited by 89 · cited 1×
“Specialist “transition clinics” or “teenager clinics” can help ease the transitional process (98, 99), and, for adolescent patients being treated with KD therapy, attendance at an adult epilepsy diet center can help ensure that an effective transition plan is in place (100).”
BackgroundThe evolution of antiepileptic drug development and regulation
Arzimanoglou, A. A., Ben‐Menachem, E., Cramer, J. A., Glauser, T. A., Seeruthun, R., & Harrison, M. (2010) · Epileptic Disorders · doi:10.1684/epd.2010.0303 · Cited by 84 · cited 1×
“Nevertheless, it can be an extremely useful medication and is approved for limited use in some European countries, on a patient-by-patient basis (58).”
BackgroundSelf-citationArzimanoglou, A. A., & Resnick, T. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0422 · Cited by 82
Self-citationCuratolo, P., Bjørnvold, M., Dill, P. E., Ferreira, J. C., Feucht, M., Hertzberg, C., Jansen, A., Jóźwiak, S., Kingswood, J. C., Kotulska, K., et al. (2016) · Drugs · doi:10.1007/s40265-016-0552-9 · Cited by 80 · cited 1×
“org September 2017 | Volume 8 | Article 505 (96, 97).”
Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy
Epilepsy Phenome/Genome Project & Epi4K Consortium (2015) · Annals of Neurology · doi:10.1002/ana.24457 · Cited by 76
Long-term prognosis of patients with Lennox–Gastaut syndrome in recent decades
Kim, H. J., Kim, H. D., Lee, J. S., Heo, K., Kim, D.-S., & Kang, H.-C. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.11.004 · Cited by 75 · cited 1×
“Clinicians should also be aware that the “classic” EEG features (SSW complexes) may evolve and/or disappear later in the disease course (16, 91).”
BackgroundSurgical options for patients with L ennox‐ G astaut syndrome
Douglass, L. M., & Salpekar, J. A. (2014) · Epilepsia · doi:10.1111/epi.12742 · Cited by 73 · cited 1×
“After corpus callosotomy or VNS therapy, generalized epileptiform discharges may be more localized and it may therefore be appropriate to re-evaluate the patient for the presence of a seizure focus following these procedures (75).”
BackgroundKerr, M., Kluger, G., & Philip, S. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0409 · Cited by 69
Long-term monitoring of the ketogenic diet: Do's and Don’ts
Bergqvist, A. G. C. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.05.020 · Cited by 69 · cited 1×
“However, consideration has to be given to duration of treatment in responders, and the risk–benefit of long-term utilization taken into consideration at all times (73).”
BackgroundCurrent Management of Tuberous Sclerosis Complex
Krueger, D. A., & Franz, D. N. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00004 · Cited by 67 · cited 1×
“org September 2017 | Volume 8 | Article 505 (96, 97).”
Gallop, K., Wild, D., Verdian, L., Kerr, M., Jacoby, A., Baker, G., Nixon, A., & Cramer, J. A. (2010) · Seizure · doi:10.1016/j.seizure.2009.10.007 · Cited by 65 · cited 1×
“LGS also has a major impact on the QoL of parents/carers and families due to restriction of social life and relationship problems between partners and other family members; feelings of isolation, which can lead to depression; problems with childcare, which can further restrict social participation and opportunities fo…”
BackgroundOpen study of clobazam in refractory epilepsy
Munn, R., & Farrell, K. (1993) · Pediatric Neurology · doi:10.1016/0887-8994(93)90026-9 · Cited by 58 · cited 1×
“Studies suggest, however, that only approximately one-third of patients develop tolerance (56, 57).”
BackgroundConry, J. A., Ng, Y., Kernitsky, L., Mitchell, W. G., Veidemanis, R., Drummond, R., Isojärvi, J. I. T., Lee, D., Paolicchi, J., & The OV‐1004 Study Investigators (2014) · Epilepsia · doi:10.1111/epi.12561 · Cited by 56 · cited 3×
“Patients completing this RCT and a previous Phase II study (54) were eligible to enter a long-term, open-label extension study (n = 267) (55).”
BackgroundKarceski, S. C. (2001) · CNS Spectrums · doi:10.1017/s1092852900001516 · Cited by 55
Livingston, J. H. (1988) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1988.tb04782.x · Cited by 54
Ketogenic diet in patients with Lennox–Gastaut syndrome
Caraballo, R. H., Fortini, S., Fresler, S., Armeno, M. L., Agustinho, A., Cresta, A., Mestre, G., & Escobal, N. (2014) · Seizure · doi:10.1016/j.seizure.2014.06.005 · Cited by 53 · cited 2×
“In a single-center prospective study, 20/61 patients with LGS were treated with KD therapy (71).”
BackgroundFollowing Catastrophic Epilepsy Patients from Childhood to Adulthood
Glauser, T. A. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.05005.x · Cited by 52 · cited 2×
“Dev Med Child Neurol (2010) 52(9):805–10.”
BackgroundElectrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Chambers, A., & Bowen, J. M. (2013) · Europe PMC (PubMed Central) · Cited by 52
Lennox‐Gastaut syndrome with late‐onset and prominent reflex seizures in trisomy 21 patients
Ferlazzo, E., Adjien, C. K., Guerrini, R., Calarese, T., Crespel, A., Elia, M., Striano, P., Gélisse, P., Bramanti, P., Bella, P. D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01944.x · Cited by 49 · cited 1×
“Patients with trisomy 21 may present with late-onset LGS, characterized by frequent reflex seizures, mostly precipitated by sudden unexpected sensory stimulation (22).”
BackgroundSelf-citationOhtsuka, Y., Yoshinaga, H., Shirasaka, Y., Takayama, R., Takano, H., & Iyoda, K. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.002 · Cited by 44
Discontinuation of Phenytoin, Carbamazepine, and Valproate in Patients with Active Epilepsy
Duncan, J. S., Shorvon, S. D., & Trimble, M. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05383.x · Cited by 43 · cited 1×
“In such cases, slow tapering is recommended and the addition of CLB for a short period can be useful (92).”
BackgroundFactors Influencing the Evolution of West Syndrome to Lennox-Gastaut Syndrome
You, S. J., Kim, H. D., & Kang, H. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.03.006 · Cited by 39
Ogawa, K., Kanemoto, K., Ishii, Y., Koyama, M., Shirasaka, Y., Kawasaki, J., & Yamasaki, S. (2001) · Seizure · doi:10.1053/seiz.2000.0483 · Cited by 34 · cited 1×
“In addition, the early development of dysphagia is strongly associated with poor long-term seizure prognosis (103), and affects patients’ ability to eat and take medication.”
BackgroundHughes, J. R., & Patil, V. K. (2002) · Clinical Electroencephalography · doi:10.1177/155005940203300103 · Cited by 33
Transitioning pediatric patients receiving ketogenic diets for epilepsy into adulthood
Kossoff, E. H., Henry-Barron, B. J., & Cervenka, M. C. (2013) · Seizure · doi:10.1016/j.seizure.2013.03.005 · Cited by 32 · cited 1×
“Specialist “transition clinics” or “teenager clinics” can help ease the transitional process (98, 99), and, for adolescent patients being treated with KD therapy, attendance at an adult epilepsy diet center can help ensure that an effective transition plan is in place (100).”
BackgroundTherapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome
Zhang, Y., Wang, Y., Zhou, Y., Zhang, L., Yu, L., & Shuizhen, Z. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.11.003 · Cited by 32 · cited 1×
“In a further retrospective study of 47 patients with LGS treated with KD therapy at a single center in China, responder rates (≥50% seizure frequency reduction) after 3 and 6 months were 49 and 53%, respectively, and 10% of patients were seizure free after 6 months (70).”
BackgroundHippocampal Neurons Express GABAAReceptor Insensitive to Diazepam in Hyperexcitable Conditions
Kapur, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01563.x · Cited by 28
Genes in Infantile Epileptic Encephalopathies
Depienne, C., Gourfinkel‐An, I., Baulac, S., & Leguern, É. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0062 · Cited by 28
Supplementary sensorimotor area seizures in children and adolescents
Bass, N. E., Wyllie, E., Comair, Y. G., Kotagal, P., Ruggieri, P. M., & Holthausen, H. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70346-2 · Cited by 28 · cited 1×
“Seizures arising from the supplementary sensorimotor area result in a set of clinical phenomena that usually include brief asymmetric tonic posturing of the extremities with preserved consciousness (27, 28).”
BackgroundAdjunctive Levetiracetam Treatment in Pediatric Lennox-Gastaut Syndrome
Kim, H. J., Kim, S. H., Kang, H., Lee, J. S., Chung, H. J., & Kim, H. D. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.06.004 · Cited by 27 · cited 1×
“An open-label, multicenter, observational clinical study assessed the efficacy and tolerability of adjunctive LEV in 55 patients with LGS over an 8-week maintenance period (63).”
BackgroundKwan, S., Lin, J., Wong, T., et al. (2006) · Seizure · doi:10.1016/j.seizure.2006.06.008 · Cited by 25 · cited 2×
“There was no statistically significant difference in outcomes between the groups, indicating that a history of West syndrome does not appear to influence postcallosotomy outcomes in LGS (87).”
BackgroundResultClobazam for Refractory Childhood Seizure Disorders - A Valuable Supplementary Drug
Munn, R., CAMFIELD, P. R., Camfield, C., & Dooley, J. M. (1988) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100028146 · Cited by 24 · cited 1×
“Studies suggest, however, that only approximately one-third of patients develop tolerance (56, 57).”
BackgroundNonconvulsive Status Epilepticus and Continuous Spike and Slow Wave of Sleep in Children
Akman, Ç. I. (2010) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2010.06.009 · Cited by 24 · cited 2×
“Patients with LGS should be regularly assessed for the development of possible NCSE, including EEG, and, where possible, EEG results should be compared with a baseline recording (93).”
BackgroundResultPujar, S. S., Calvert, S., Cortina‐Borja, M., Chin, R., Smith, R. A., Cross, J. H., Das, K. B., Pitt, M. C., & Scott, R. C. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.07.013 · Cited by 21 · cited 2×
“It should also be noted that spontaneous fluctuations in the frequency and type of seizures are likely to occur (35).”
BackgroundSelf-citationLennox‐Gastaut SyndTome Considerations in Its Concept and Categorization
Ohtahara, S. (1988) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1988.tb01349.x · Cited by 16
Lee, E. H., Yum, M., Choi, H.-W., & Ko, T. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182770730 · Cited by 14
Epileptic Encephalopathies in Childhood: The Role of Genetic Testing
Syrbe, S., & Lemke, J. R. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552623 · Cited by 11 · cited 1×
“org September 2017 | Volume 8 | Article 505 prevent unnecessary diagnostic investigations (19).”
BackgroundKhan, S. A., Carney, P. W., & Archer, J. S. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.09.011 · Cited by 4 · cited 1×
“Moreover, focal frontal or parietal epilepsies can be differentiated from LGS as the interictal EEG usually shows normal background activity, the ictal EEG in tonic asymmetric seizures can be normal, and fast spike discharges are either localized over the vertex or diffuse but clearly asymmetric (29).”
Background
Cited by
Knupp, K. G., Scheffer, I. E., Ceulemans, B., Sullivan, J. E., Nickels, K. C., Lagae, L., Guerrini, R., Zuberi, S. M., Nabbout, R., Riney, K., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0829 · Cited by 137
“At baseline, 233 of 263 patients (89%) were using 2 to 4 concomitant ASMs (median [range] number, 3 [1-5]).”
BackgroundHahn, C. D., Jiang, Y., Villanueva, V., Zolnowska, M., Arkilo, D., Hsiao, S., Asgharnejad, M., & Dlugos, D. (2022) · Epilepsia · doi:10.1111/epi.17367 · Cited by 81
The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
Strzelczyk, A., Zuberi, S. M., Striano, P., Rosenow, F., & Schubert-Bast, S. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02626-4 · Cited by 68
“However, importantly, it has also become clear that there are caveats to these features which can make LGS challenging to define and diagnose [5].”
BackgroundSelf-citationKnupp, K. G., Scheffer, I. E., Ceulemans, B., Sullivan, J., Nickels, K. C., Lagae, L., Guerrini, R., Zuberi, S. M., Nabbout, R., Riney, K., et al. (2023) · Epilepsia · doi:10.1111/epi.17431 · Cited by 55
Metadata
- Authors
- Cross, J. H., Auvin, S., Falip, M., Striano, P., & Arzimanoglou, A.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-29
- Volume
- 8
- Pages
- 505-505
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2760749448
- Cited by
- 205
- References
- 96
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.